References
- Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335(8697):1078–80.
- The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47.
- Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med. 1999;341(17):1284–91.
- Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility. Nat Genet. 2017;49(3):438–43.
- de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behcet's disease: A systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287–96.
- Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, et al. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the silk road: A literature survey. Ocul Immunol Inflamm. 2017;25(1):37–40.
- Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, et al. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behcet's disease: A nationwide survey. Mod Rheumatol. 2019;1–7.
- Mizuki N, Ohno S, Ando H, Chen L, Palimeris GD, Stavropoulos-Ghiokas E, et al. A strong association between HLA-B*5101 and Behcet's disease in Greek patients. Tissue Antigens. 1997;50(1):57–60.
- Nakamura J, Meguro A, Ishii G, Mihara T, Takeuchi M, Mizuki Y, et al. The association analysis between HLA-A*26 and Behcet's disease. Sci Rep. 2019;9(1):4426.
- Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis. 2010;69(4):747–54.
- Kaburaki T, Takamoto M, Numaga J, Kawashima H, Araie M, Ohnogi Y, et al. Genetic association of HLA-A*2601 with ocular Behcet's disease in Japanese patients. Clin Exp Rheumatol 2010;28(4 Suppl 60):S39–S44.
- Kobashigawa T, Nanke Y, Kawamoto M, Yago T, Yamanaka H, Kotake S. Relationship between HLA-A or -B loci and behcet's disease in Japan. B51 is related to pathogenesis and A26 is related to ocular lesions. Ann Rheum Dis. 2013;72(Suppl 3):643.
- Japanese Ministry of Health, Labour and Welfare. Statutory intractable diseases. Implemented on January 1, 2015 [Japanese]. Available from: www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000062437.html [last accessed 1 Aug 2019].
- Japan Intractable Diseases Information Center. Behcet Disease. [Japanese]. Avilable from: from: http://www.nanbyou.or.jp/entry/330 [last accessed 1 Aug 2019].
- Japanese Ministry of Health, Labour and Welfare. Ethical Guidelines for Medical and Health Research Involving Human Subjects. 2015. Available from: http://www.lifescience.mext.go.jp/files/pdf/n1500_01.pdf#search='Ethics+Review+Procedures+concerning+Research+with+Human+Subjects+published+in+2015+by+Ministry+of+Health%2C+Labour+and+Welfare%2C+Japan' [last accessed 1 Aug 2019].
- Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol. 2005;50(4):297–350.